Comparison of the effects of isoflurane and sevoflurane on protein tyrosine phosphorylation-mediated vascular contraction

Acta Anaesthesiologica Scandinavica

Volumn 49, Issue 6, 2005, Pages 852-858

  Yu, J ^a   Mizumoto, K ^a   Kakutani, T ^a   Hasegawa, A ^a   Ogawa, K ^a   Hatano, Yoshio ^a  

^a WAKAYAMA MEDICAL UNIVERSITY   (Japan)

Author keywords

Anesthetics; Contraction; Isoflurane; Mechanism; Protein tyrosine phosphorylation; Sevoflurane; Smooth muscle; Vasculature; Volatile

Indexed keywords

GENISTEIN; ISOFLURANE; PHOSPHOPROTEIN PHOSPHATASE INHIBITOR; PROTEIN TYROSINE KINASE; PROTEIN TYROSINE KINASE INHIBITOR; SEVOFLURANE; VANADATE SODIUM;

ANIMAL TISSUE; AORTA; ARTICLE; BLOOD PRESSURE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DENSITY; DOSE RESPONSE; DRUG EFFECT; ENZYME MECHANISM; MALE; MUSCLE CONTRACTION; MUSCLE ISOMETRIC CONTRACTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT; REGULATORY MECHANISM; VASCULAR SMOOTH MUSCLE; VASCULARIZATION; VASOCONSTRICTION; WESTERN BLOTTING;

ANESTHETICS, INHALATION; ANIMALS; AORTA, THORACIC; ENZYME INHIBITORS; GENISTEIN; ISOFLURANE; MALE; METHYL ETHERS; MUSCLE CONTRACTION; MUSCLE, SMOOTH, VASCULAR; PHOSPHORYLATION; PROTEIN-TYROSINE-PHOSPHATASE; RATS; RATS, WISTAR; TYROSINE; VANADATES;

EID: 21744438119     PISSN: 00015172     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1399-6576.2005.00699.x     Document Type: Article

References (40)

1. Torri G, Casati A. Cardiovascular homeostasis during inhalational general anesthesia: a clinical comparison between sevoflurane and isoflurane. On behalf of the Italian research group on sevoflurane. J Clin Anesth 2000; 12: 117-22.
2. Peduto VA, Peli S, Amicucci G et al. Maintenance of and recovery from anaesthesia in elderly patients, a clinical comparison between sevoflurane and isoflurane. Minerva Anestesiol 1998; 64 (9 Suppl. 3): 18-25.
3. Nakamura K, Toda H, Hatano Y, Mori K. Comparison of direct effects of sevoflurane, isoflurane and halothane on isolated canine coronary arteries. Can J Anesth 1993; 40: 257-61.
4. Akata T, Izumi K, Nakashima M. The action of sevoflurane on vascular smooth muscle of isolated mesenteric resistance arteries (part 2): Mechanisms of endothelium-independent vasorelaxation. Anesthesiology 2000; 92: 1441-53.
5. Hughes AD, Wijetunge S. Role of tyrosine phosphorylation in excitation-contraction coupling in vascular smooth muscle. Acta Physiol Scand 1998; 164: 457-69.
6. 2 sensitivity for contraction of smooth muscle. Can J Physiol Pharmacol 1994; 72: 1434-9.
7. Zhang XP, List WF. Effects of halothane, isoflurane and sevoflurane on calcium-related contraction in porcine coronary-arteries. Acta Anaesthesiol Scand 1996; 40: 815-9.
8. Akata T, Nakashima M, Izumi K. Comparison of volatile anesthetic actions on intracellular calcium stores of vascular smooth muscle: investigation in isolated systemic resistance arteries. Anesthesiology 2001; 94: 840-50.
9. Molloy CJ, Taylor DS, Weber H. Angiotensin II stimulation of rapid protein tyrosine phosphorylation and protein kinase activation in aortic smooth muscle cells. J Biol Chem 1993; 268: 7338-45.
10. Smith PK, Krohn RI, Hermanson GT et al. Measurement of protein using bicinchoninic acid. Anal Biochem 1985; 150: 76-85.
11. 8]- vasopressin-activated increases in protein tyrosine phosphorylation and cellular calcium in A7r5 aortic smooth muscle cells. Arch Biochem Biophys 1996; 326: 271-80.
12. Kaplan N, Nelson SR, Di Salvo J. Protein tyrosine phosphorylation in smooth muscle: a potential coupling mechanism between receptor activation and intracellular calcium. Proc Soc Exp Biol Med 1997; 214: 285-301.
13. Marrero MB, Paxton WG, Duff JL, Berk BC, Bernstein KE. Angiotensin II stimulates tyrosine phosphorylation of phospholipase c-γ1 in vascular smooth muscle cells. J Biol Chem 1994; 269: 10935-9.
14. Meisenhelder J, Suh P, Rhee SG, Hunter T. Phospholipase C-gamma is a substrate for the PDGP and EGP receptor protein-tyrosine kinases in vivo and in vitro. Cell 1989; 57: 1109-20.
15. Khalil RA, Menice CB, Wang C-LA, Morgan KG. Phosphotyrosine-dependent targeting of mitogen-activated protein kinase in differentiated contractile vascular cells. Circ Res 1995; 76: 1101-8.
16. Ishihata A, Tasaki K, Katano Y. Involvement of p44/42 mitogen-activated protein kinases in regulating angiotensin II- and endothelin-1-induced contraction of rat thoracic aorta. Eur J Pharmacol 2002; 445: 247-56.
17. Tsuda T, Kawahara Y, Shii K, Koide M, Ishida Y, Yokoyama M. Vasoconstrictor-induced protein-tyrosine phosphorylation in cultured vascular smooth muscle cells. FEBS Lett 1991; 285: 44-8.
18. i sensitization pathways. Hypertension 2002; 39: 543-9.
19. Abebe W, Agrawal DK. Role of tyrosine kinases in norepinephrine-induced contraction of vascular smooth muscle. J Cardiovasc Pharmacol 1995; 26: 153-9.
20. Di Salvo J, Steusloff A, Semenchuk L, Satoh S, Kolquist K, Pfitzer G. Tyrosine kinase inhibitors suppress agonist-induced contraction in smooth muscle. Biochem Biophys Res Commun 1993; 190: 968-74.
21. Filipeanu CM, Brailoiu E, Huhurez G, Slatineanu S, Baltatu O, Branisteanu DD. Multiple effects of tyrosine kinase inhibitors on vascular smooth muscle contraction. Euro J Pharmacol 1995; 281: 29-35.
22. 2+ mobilization in swine carotid artery. Am J Physiol 1995; 268: 1425-9.
23. Swarup G, Cohen S, Garbers DL. Inhibition of membrane phosphotyrosyl phosphatase activity by vanadate. Biophy Res Commun 1982; 107: 1104-9.
24. Di Salvo J, Semenchuk LA, Lauer J. Vanadate-induced contraction of smooth muscle and enhanced protein tyrosine phosphorylation. Arch Biochem Biophys 1993; 304: 386-91.
25. St-Louis J, Sicotte B, Breton E, Srivastava AK. Contractile effects of vanadate on aorta rings from virgin and pregnant rats. Mol Cell Biochem 1995; 153: 145-50.
26. Tomiyasu S, Hara T, Hasuo H, Ureshino H, Sumikawa K. Comparative analysis of systemic and coronary hemodynamics during sevoflurane- and isoflurane-induced hypotension in dogs. J Cardiovasc Pharmacol 1999; 33: 741-7.
27. Conzen PF, Vollmar B, Habazettl H et al. Systemic and regional hemodynamics of isoflurane and sevoflurane in rats. Anesth Analg 1992; 74: 79-88.
28. Hirano M, Fujigaki T, Shibata O, Sumikawa K. A comparison of coronary hemodynamics during isoflurane and sevoflurane anesthesia in dogs. Anesth Analg 1995; 80: 651-6.
29. Summors AC, Gupta AK, Matta BF. Dynamic cerebral autoregulation during sevoflurane anesthesia: a comparison with isoflurane. Anesth Analg 1999; 88: 341-5.
30. Matta BF, Heath KJ, Tipping K, Summors AC. Direct cerebral vasodilatory effects of sevoflurane and isoflurane. Anesthesiology 1999; 91: 677-80.
31. Holmstrom A, Akeson J. Desflurane increase intracranial pressure more and sevoflurane less than isoflurane in pigs subjected to intracranial hypertension. J Nuerosurg Anesthesiol 2004; 16: 136-43.
32. 2+ mobilization in aortic smooth muscle cells from hypertensive rats: implication of cytoskeleton. Anesthesiology 2002; 97: 642-51.
33. 2+-elicited, contraction of rat aortic smooth muscle. Anesthesiology 2004; 100: 879-84.
34. Su JY, Vo AC. Role of PKC in isoflurane-induced biphasic contraction in skinned pulmonary arterial strips. Anesthesiology 2002; 96: 155-61.
35. 2+-calmodulin-dependent protein kinase II plays a major role in halothane-induced dose-dependent relaxation in the skinned pulmonary artery. Anesthesiology 2002; 97: 207-14.
36. YuJ, Ogawa K, Tokinaga Y et al. Sevoflurane inhibits GTPγS- stimulated, Rho/Rho-kinase-mediated contraction of isolated rat aortic smooth muscle. Anesthesiology 2003; 99: 646-51.
37. Spurrell BE, Murphy TV, Hill MA. Tyrosine phosphorylation modulates arteriolar tone but is not fundamental to myogenic response. Am J Physiol 2000; 278: H373-82.
38. Murphy TV, Spurrell BE, Hill MA. Tyrosine phosphorylation following alterations in arteriolar intraluminal pressure and wall tension. Am J Physiol 2001; 281: H1047-56.
39. Murphy TV, Spurrell BE, Hill MA. Cellular signalling in arteriolar myogenic constriction: involvement of tyrosine phosphorylation pathways. Clin Exp Pharmacol Physiol 2002; 29: 612-9.
40. Ward DT, Alder AC, Ohanian J, Ohanian V. Noradrenaline-induced paxillin phosphorylation, ERK activation and MEK-regulated contraction in intact rat mesenteric arteries. J Vasc Res 2002; 39: 1-11.